BOSTON (AP) — BOSTON (AP) — Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported a loss of $30.8 million in its fourth quarter.
The Boston-based company said it had a loss of 63 cents per share.
For the year, the company reported that its loss widened to $108.5 million, or $2.30 per share.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GLUE at https://www.zacks.com/ap/GLUE
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.